CLRB
Cellectar BiosciencesBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
The bull case is that iopofosine still has a live regulatory path, with the company citing EMA feedback that supports a planned Q3 2026 CMA submission and the 10-K describing a post-EOP2 path toward potential accelerated and full approval in WM. If regulators accept the filing package and the post-BTKi dataset remains compelling, CLRB could rerate sharply from a deeply depressed micro-cap base.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
CLR 125 is an early Phase 1b asset, so mid-2026 readouts may be noisy and not enough to support the broader valuation alone [#8-K-2026-03-04].
Momentum
69
Value
41
Sentiment
63
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $2.80 · Bull $5.00 · Bear $1.40
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-19 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $11.50
Why
Momentum69 · Δ7d -
Value41 · Δ7d +0.0
Sentiment63 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Sentiment · See AI snapshot
Momentum
69
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
63
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 69.2 / Value 41.1 / Sentiment 62.9
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$20.14M
Beta
0.30
Shares Out
7.99M
P/E (TTM) · Derived
-0.3
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.38
Rev YoY
-
EPS YoY
-69.0%
Gross Margin
-
Op Margin
-
Net Debt
-$12.79M
Current Ratio
1.90
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology